INTRODUCTION: Fibrinogen is one of the essential coagulation factors. Preoperative lower plasma fibrinogen level has been associated with higher blood loss. Scoliosis surgery presents a challenge for the anaesthetic team, one of the reasons being blood loss and transfusion management. Recently, the prophylactic fibrinogen administration has been a debated topic in various indications. It has been described for example, in urological or cardiovascular surgery, as well as in paediatrics. This pilot study is focused on verifying the feasibility of potential large randomised trial and verifying the safety of prophylactic fibrinogen administration in paediatric scoliosis surgery. METHODS AND ANALYSIS: A total of 32 paediatric patients indicated for scoliosis surgery will be recruited. Participants will be randomised into study groups in a 1:1 allocation ratio. Patients in the intervention group will receive prophylactic single dose of fibrinogen, in addition to standard of care. Patients in the control group will receive standard of care without study medication prior to skin incision. The primary aim is to assess the safety of prophylactic fibrinogen administration during scoliosis surgery in children, the incidence of any adverse events (AEs) and reactions will be monitored during participation in the study. The secondary objective is to investigate the additional safety information, feasibility and efficacy of a prophylactic fibrinogen administration. The incidence of AEs and reactions according to selected adverse events of special interest will be monitored. All collected data will be subjected to statistical analysis according to a separate statistical analysis plan. ETHICS AND DISSEMINATION: This trial follows the applicable legislation and requirements for good clinical practice according to the International Conference on Harmonisation E6(R2). All essential trial documents were approved by the relevant ethics committee and national regulatory authority (State Institute for Drug Control) and their potential amendments will be submitted for approval. TRIAL REGISTRATION NUMBER: NCT05391412.

Department of Anaesthesiology and Intensive Care Medicine Masaryk University Faculty of Medicine Brno Czech Republic

Department of Anaesthesiology and Intensive Care Medicine University Hospital Brno Brno Czech Republic

Department of Orthopaedic Surgery Masaryk University Faculty of Medicine Brno Czech Republic

Department of Orthopaedic Surgery University Hospital Brno Brno Czech Republic

Department of Pharmacology CZECRIN Masaryk University Faculty of Medicine Brno Czech Republic

See more in PubMed

El-Hawary R, Chukwunyerenwa C. Update on evaluation and treatment of Scoliosis. Pediatr Clin North Am 2014;61:1223–41. 10.1016/j.pcl.2014.08.007 PubMed DOI

Kim HJ, Blanco JS, Widmann RF. Update on the management of idiopathic Scoliosis. Curr Opin Pediatr 2009;21:55–64. 10.1097/MOP.0b013e328320a929 PubMed DOI

Konieczny MR, Senyurt H, Krauspe R. Epidemiology of adolescent idiopathic Scoliosis. J Child Orthop 2013;7:3–9. 10.1007/s11832-012-0457-4 PubMed DOI PMC

Parr A, Askin G. Paediatric Scoliosis: update on assessment and treatment. Aust J Gen Pract 2020;49:832–7. 10.31128/AJGP-06-20-5477 PubMed DOI

Sheehan DD, Grayhack J. Pulmonary implications of pediatric spinal deformities. Pediatr Clin North Am 2021;68:239–59. 10.1016/j.pcl.2020.09.012 PubMed DOI

Weissmann KA, Lafage V, Pitaque CB, et al. . Neuromuscular Scoliosis: Comorbidities and complications. Asian Spine J 2021;15:778–90. 10.31616/asj.2020.0263 PubMed DOI PMC

Gibson PRJ. Anaesthesia for correction of Scoliosis in children. Anaesth Intensive Care 2004;32:548–59. 10.1177/0310057X0403200413 PubMed DOI

Chen W, Shen J, Zhang Y, et al. . A randomised controlled trial of fibrinogen concentrate during Scoliosis surgery. Anaesthesia 2020;75:1476–81. 10.1111/anae.15124 PubMed DOI

Lavoie J. Blood transfusion risks and alternative strategies in pediatric patients. Paediatr Anaesth 2011;21:14–24. 10.1111/j.1460-9592.2010.03470.x PubMed DOI

Wang M, Zheng X-F, Jiang L-S. Efficacy and safety of antifibrinolytic agents in reducing perioperative blood loss and transfusion requirements in Scoliosis surgery: A systematic review and meta-analysis. PLoS ONE 2015;10:e0137886. 10.1371/journal.pone.0137886 PubMed DOI PMC

McNicol ED, Tzortzopoulou A, Schumann R, et al. . Antifibrinolytic agents for reducing blood loss in Scoliosis surgery in children. Cochrane Database Syst Rev 2016;9:CD006883. 10.1002/14651858.CD006883.pub3 PubMed DOI PMC

Klein AA, Bailey CR, Charlton AJ, et al. . Association of Anaesthetists guidelines: cell salvage for peri-operative blood conservation 2018. Anaesthesia 2018;73:1141–50. 10.1111/anae.14331 PubMed DOI

May JE, Wolberg AS, Lim MY. Disorders of fibrinogen and Fibrinolysis. Hematol Oncol Clin North Am 2021;35:1197–217. 10.1016/j.hoc.2021.07.011 PubMed DOI PMC

Kattula S, Byrnes JR, Wolberg AS. Fibrinogen and fibrin in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol 2017;37:e13–21. 10.1161/ATVBAHA.117.308564 PubMed DOI PMC

Naik BI, Pajewski TN, Bogdonoff DI, et al. . Rotational Thromboelastometry-guided blood product management in major spine surgery. J Neurosurg Spine 2015;23:239–49. 10.3171/2014.12.SPINE14620 PubMed DOI

Geck MJ, Singh D, Gunn H, et al. . Is preoperative fibrinogen testing associated with total blood loss in adolescent idiopathic Scoliosis correction? Spine Deform 2017;5:381–6. 10.1016/j.jspd.2017.05.001 PubMed DOI

Geck MJ, Singh D, Gunn H, et al. . Relationship between preoperative plasma fibrinogen concentration, perioperative bleeding, and transfusions in elective adult spinal deformity correction. Spine Deform 2019;7:788–95. 10.1016/j.jspd.2018.12.001 PubMed DOI

Carling MS, Jeppsson A, Wessberg P, et al. . Preoperative fibrinogen plasma concentration is associated with perioperative bleeding and transfusion requirements in Scoliosis surgery. Spine (Phila Pa 1976) 2011;36:549–55. 10.1097/BRS.0b013e3181d952dc PubMed DOI

Grottke O, Schöchl H, Levy JH, et al. . Supplementary fibrinogen in the management of bleeding: re-evaluation of data from clinical trials. Br J Anaesth 2018;120:407–9. 10.1016/j.bja.2017.11.092 PubMed DOI

Ranucci M, Baryshnikova E, Crapelli GB, et al. . Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. J Am Heart Assoc 2015;4:e002066. 10.1161/JAHA.115.002066 PubMed DOI PMC

Soleimani M, Masoumi N, Nooraei N, et al. . The effect of fibrinogen concentrate on perioperative bleeding in Transurethral resection of the prostate: a double-blind placebo-controlled and randomized study. J Thromb Haemost 2017;15:255–62. 10.1111/jth.13575 PubMed DOI

Fathi M, Lashay A, Massoudi N, et al. . Fibrinogen prophylaxis for reducing perioperative bleeding in patients undergoing radical cystectomy: A double-blind placebo-controlled randomized trial. J Clin Anesth 2021;73:110373. 10.1016/j.jclinane.2021.110373 PubMed DOI

Haas T, Spielmann N, Restin T, et al. . Higher fibrinogen concentrations for reduction of transfusion requirements during major Paediatric surgery: A prospective randomised controlled trial. Br J Anaesth 2015;115:234–43. 10.1093/bja/aev136 PubMed DOI

Chan A-W, Tetzlaff JM, Altman DG, et al. . SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013;158:200–7. 10.7326/0003-4819-158-3-201302050-00583 PubMed DOI PMC

European Parliament and Council of the European Union . Directive 2001/20/EC of the European Parliament and the Council of 4 Apr 2001. OJ L 121: 34–44. 2001. Available: http://eudract.emea.eu.int/docs/Dir2001–20_en.pdf

Hertzog MA. Considerations in determining sample size for pilot studies. Res Nurs Health 2008;31:180–91. 10.1002/nur.20247 PubMed DOI

Thabane L, Ma J, Chu R, et al. . A Tutorial on pilot studies: the what, why and how. BMC Med Res Methodol 2010;10:1. 10.1186/1471-2288-10-1 PubMed DOI PMC

Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract 2004;10:307–12. PubMed

Kozek-Langenecker SA, Ahmed AB, Afshari A, et al. . Management of severe perioperative bleeding: guidelines from the European society of Anaesthesiology: first update 2016. Eur J Anaesthesiol 2017;34:332–95. 10.1097/EJA.0000000000000630 PubMed DOI

Carling MS, Zarhoud J, Jeppsson A, et al. . Preoperative plasma fibrinogen concentration, factor XIII activity, perioperative bleeding, and transfusions in elective Orthopaedic surgery: A prospective observational study. Thromb Res 2016;139:142–7. 10.1016/j.thromres.2016.01.001 PubMed DOI

Haas T, Goobie S, Spielmann N, et al. . Improvements in patient blood management for pediatric Craniosynostosis surgery using a ROTEM(®) -Assisted strategy - feasibility and costs. Paediatr Anaesth 2014;24:774–80. 10.1111/pan.12341 PubMed DOI PMC

Goobie SM, Zurakowski D, Glotzbecker MP, et al. . Tranexamic acid is efficacious at decreasing the rate of blood loss in adolescent Scoliosis surgery: A randomized placebo-controlled trial. J Bone Joint Surg Am 2018;100:2024–32. 10.2106/JBJS.18.00314 PubMed DOI

Shrestha IK, Ruan T-Y, Lin L, et al. . The efficacy and safety of high-dose tranexamic acid in adolescent idiopathic Scoliosis: a meta-analysis. J Orthop Surg Res 2021;16:53. 10.1186/s13018-020-02158-8 PubMed DOI PMC

Hasan MS, Yunus SN, Ng CC, et al. . Tranexamic acid in pediatric Scoliosis surgery: A prospective randomized trial comparing high-dose and low-dose tranexamic acid in adolescent idiopathic Scoliosis undergoing posterior spinal fusion surgery. Spine (Phila Pa 1976) 2021;46:E1170–7. 10.1097/BRS.0000000000004076 PubMed DOI

Palmer AJR, Gagné S, Fergusson DA, et al. . Blood management for elective Orthopaedic surgery. J Bone Joint Surg Am 2020;102:1552–64. 10.2106/JBJS.19.01417 PubMed DOI

Myers SP, Kutcher ME, Rosengart MR, et al. . Tranexamic acid administration is associated with an increased risk of Posttraumatic venous thromboembolism. J Trauma Acute Care Surg 2019;86:20–7. 10.1097/TA.0000000000002061 PubMed DOI

Roberts I, Shakur-Still H, Afolabi A, et al. . Effects of a high-dose 24-H infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial. The Lancet 2020;395:1927–36. 10.1016/S0140-6736(20)30848-5 PubMed DOI PMC

Ng KT, Yap JLL, Kwok PE. The effect of fibrinogen concentrate on postoperative blood loss: A systematic review and meta-analysis of randomized controlled trials. J Clin Anesth 2020;63:109782. 10.1016/j.jclinane.2020.109782 PubMed DOI

See more in PubMed

ClinicalTrials.gov
NCT05391412